7984 Primary Hysteroscopic Treatment of First Trimester Miscarriage Using Resectoscope - a Pilot Study

Abstract

<h3>Study Objective</h3> To determine the feasibility and safety of hysteroscopic resection using standard resectoscope for uterine evacuation of first-trimester miscarriage. <h3>Design</h3> A prospective feasibility study. <h3>Setting</h3> Academic, tertiary-care medical center. <h3>Patients or Participants</h3> Women diagnosed with early miscarriage up to 12 weeks from last menstrual period. <h3>Interventions</h3> Overall, in this pilot study, 15 women were recruited for hysteroscopic evacuation of the uterine cavity between April 2021 and October 2021. All procedures were performed under general anesthesia by Versapoint 2 Bipolar Resectoscope 24Fr (J&J, Germany). <h3>Measurements and Main Results</h3> Collected data, including demographic characteristics, pregnancy-sac size and location, length of procedure, as well as intra and postoperative adverse events, were recorded. The mean duration of the procedure was 14.3 ± 3.7 minutes. Complete evacuation was recorded in all cases, and no adverse events occurred during any procedure. Post- procedure follow-up was conducted by office hysteroscopy in 10 women and by ultrasonography in 5 women. In one case, retained products of conception were diagnosed in the office hysteroscopy and were removed using the "see-and-treat" technique without anesthesia. The diagnosis was confirmed pathologically. <h3>Conclusion</h3> Hysteroscopic evacuation using resectoscope for the treatment of early miscarriage is a safe and feasible technique. Randomized trials are needed to examine the efficacy of hysteroscopic treatment compared with traditional dilation and curettage.